Read + Share
Zhou C, Chen G, Huang Y, Zhou J, et al. Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced
Nonsquamous NSCLC: Extended Follow-Up of CameL Phase 3 Trial. J Thorac Oncol 2023;18:628-639.
PMID: 36646210
|
 |
|
Zhou C, Chen G, Huang Y, Zhou J, et al. Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced
Nonsquamous NSCLC: Extended Follow-Up of CameL Phase 3 Trial. J Thorac Oncol 2023;18:628-639.
PMID: 36646210
|
|
|
|